MediPharm Labs Corp. (TSX:LABS)

Market Cap	27.62M -33.5%
Revenue (ttm)	45.12M +7.5%
Net Income	-8.27M
EPS	-0.02
Shares Out	424.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	65,227
Average Volume	200,031
Open	0.0650
Previous Close	0.0650
Day's Range	0.0650 - 0.0700
52-Week Range	0.0600 - 0.1100
Beta	0.87
RSI	48.12
Earnings Date	Mar 30, 2026

About MediPharm Labs

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, develops, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll canna...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 127
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2025, MediPharm Labs's revenue was 45.12 million, an increase of 7.54% compared to the previous year's 41.96 million. Losses were -8.27 million, -22.69% less than in 2024.